AQ BioMed

AQ BioMed is a medical device company commercializing next generation glaucoma drainage device to address the $3B glaucoma market. Based on over 20 years of research and development, the patented Oculieve™ drainage device is implanted in the eye by a MIGS (Minimally Invasive Glaucoma Surgery) to relieve over-pressurization caused by glaucoma.